Abstract:Objective To explore the changes of blood glucose after total pancreaticoduodenectomy and the feasibility and effectiveness of autologous islet cell transplantation in the treatment of postoperative diabetes. Methods SD rats were randomly divided into a control group, an operation group and an experimental group (operation+autologous islet transplantation), each group had 10 rats. The rats of the control group did not have any treatment, while the rats of the operation goup and the experimental group were treated with total pancreaticoduodenectomy. The pancreatic islet cells were isolated and purified from the pancreas after total pancreatectomy. The autologous islet cells were implanted into the liver through the portal vein. Blood glucose, C-peptide and glycosylated hemoglobin were monitored in each group to determine the islet function after transplantation. Results Blood glucose was significantly increased [(20.58 ± 2.00) mmol/L] on the 1st day after total pancreatectomy in the operation group compared with the control group (P < 0.05). After autologous islet cell transplantation, the blood glucose of the experimental group decreased significantly compared to the simple operation group (P < 0.05). Detection of the serum levels of glycosylated hemoglobin 4 months after operation showed that compared with the control group, the serum glycosylated hemoglobin level of the operation group was significantly higher than that of the control group (P < 0.05). There was a significant difference in the serum level of glycosylated hemoglobin between the experimental group and the operation group (P < 0.05). Conclusions Total pancreaticoduodenectomy is a safe and reliable way to establish the rat diabetic model. Autologous islet cell transplantation is an effective way to treat rat diabetes after total pancreatectomy. This experiment provides experimental basis for clinical application.